Sign in

CIK 0000711377 · Large accelerated filer

NEOGEN CORP

Sign in to watch
Ticker
NEOG
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
May 31
Incorporated
MI
Entity type
operating
EIN
382367843
Phone
5173729200
Business address
620 LESHER PLACE, LANSING, MI, 48912
Open-market buys, last 90 days
$6,035
in 1 filing
Open-market sales, last 90 days
$114,676
in 1 filing

Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Yarwood Jeremy −$115K Chief Scientific Officer sold 100% of stake
  2. Nassif Mikheal +$6K CEO 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-01 Stacey Jennifer Evans Chief Legal Officer Grant or award +39,349 $9.53 $375K 39,349
2026-05-01 Stacey Jennifer Evans Chief Legal Officer Grant or award · Common Stock (Right to Buy) +89,520 89,520
2026-02-17 Nassif Mikheal CEO Purchase +23 $10.94 $252 704
2026-02-02 Nassif Mikheal CEO Purchase +24 $10.00 $240 681
2026-01-26 Nassif Mikheal CEO Purchase +25 $9.86 $246 657
2026-01-16 Nassif Mikheal CEO Purchase +137 $9.33 $1K 632
2026-01-07 Ranalli Tamara A. Senior Vice President Grant or award +50,813 $7.38 $375K 50,813
2026-01-07 Ranalli Tamara A. Senior Vice President Grant or award +50,813 $7.38 $375K 50,813
2026-01-07 Ranalli Tamara A. Senior Vice President Grant or award · Common Stock (Right to Buy) +261,210 261,210
2026-01-07 Ranalli Tamara A. Senior Vice President Grant or award +50,813 $7.38 $375K 50,813
2026-01-07 Ranalli Tamara A. Senior Vice President Grant or award · Common Stock (Right to Buy) +130,605 130,605
2025-12-01 Naemura David H. Former CFO Option exercise +12,912 $5.98 $77K 93,936
2025-12-01 Naemura David H. Former CFO Shares withheld for taxes −3,548 $5.98 $21K 90,388
2025-12-01 Naemura David H. Former CFO Option exercise · Restricted Stock Units −12,912 $5.98 $77K 0
2025-11-03 Nassif Mikheal CEO Purchase +177 $6.25 $1K 495
2025-11-03 Riggsbee Richard Bryan CFO Grant or award +178,855 $6.29 $1.1M 178,855
2025-11-03 Riggsbee Richard Bryan CFO Grant or award · Common Stock (Right to Buy) +459,713 459,713
2025-10-27 BOREL JAMES C Director Option exercise +1,777 $6.19 $11K 96,347
2025-10-27 BOREL JAMES C Director Option exercise · Restricted Stock Units −1,777 $6.19 $11K 1,777
2025-10-27 CAPELLO JEFFREY D Director Option exercise +1,777 $6.19 $11K 32,502

Page 4 of 11 · 210 trades